DEF: Bollinger Innovations Seeks Reverse Split to Stay Listed
Proxy Statement for Special Meeting
Bollinger Innovations, Inc. is seeking stockholder approval for a reverse stock split to address ongoing non-compliance with Nasdaq's minimum bid price requirement and avoid delisting.
Summary
- Stockholders are invited to a Special Meeting on September 11, 2025, to vote on two proposals: a reverse stock split and an adjournment proposal.
- Proposal 1 seeks approval for an amendment to the company's Certificate of Incorporation to effect a reverse stock split of outstanding common stock at a ratio between 1-for-2 and 1-for-250, at the Board's discretion.
- The primary purpose of the reverse stock split is to increase the per-share market price of common stock to meet Nasdaq's $1.00 minimum bid price requirement and maintain listing.
- The company has a history of non-compliance with Nasdaq listing rules, having effected multiple reverse stock splits in recent years: 1-for-25 on May 4, 2023; 1-for-9 on August 11, 2023; 1-for-100 on December 21, 2023; 1-for-100 on September 17, 2024; 1-for-60 on February 18, 2025; 1-for-100 on April 11, 2025; 1-for-100 on June 2, 2025; and 1-for-250 on August 4, 2025.
- As of the proxy statement date, the company has not received a deficiency notice regarding the Bid Price Rule, but its common stock has closed below $1.00 since August 14, 2025.
- The company also received a notice on February 25, 2025, for non-compliance with Nasdaq's Market Value of Listed Securities (MVLS) rule ($35.0 million minimum) and failed to regain compliance by the August 25, 2025 deadline, intending to request a hearing.
- If approved, this will be the company's 'final reverse stock split,' meaning no further reverse splits for 36 months from its effective date resulting from this proposal.
- Proposal 2 seeks approval to adjourn the Special Meeting if necessary to solicit additional proxies or establish a quorum.
Sentiment
Score: 3
Explanation: The company is facing severe and persistent listing challenges, evidenced by multiple recent reverse stock splits and ongoing non-compliance with Nasdaq's bid price and market value rules. This indicates significant underlying operational or market perception issues and a precarious financial position, leading to a highly negative outlook.
Positives
- The proposed reverse stock split aims to maintain the company's listing on The Nasdaq Capital Market, preventing potential delisting and its adverse effects on liquidity and marketability.
- An increased market price per share could potentially improve the marketability and liquidity of common stock, attracting broader investor interest.
- A higher stock price may improve the perception of the company's common stock as a viable investment security, potentially overcoming institutional policies against low-priced stocks.
Negatives
- There is no assurance that the reverse stock split will achieve or maintain the desired increase in stock price for any meaningful period.
- The reverse stock split will reduce the total number of outstanding shares, which may decrease trading volume and the number of market makers, potentially reducing liquidity.
- Nasdaq may view a series of reverse stock splits negatively, potentially undermining investor confidence and leading to delisting even if bid price compliance is temporarily achieved.
- Due to prior reverse stock splits, if the company effects another reverse stock split and subsequently fails the Bid Price Rule, it will not be eligible for a Minimum Bid Price Rule Compliance Period and will face immediate delisting proceedings.
- The reverse stock split may result in more stockholders owning 'odd lots' (less than 100 shares), which can incur higher transaction costs per share.
- The market may view the reverse stock split negatively, potentially leading to a decrease in the company's overall market capitalization if the per-share price does not increase proportionally.
Risks
- Expected benefits of the reverse stock split, such as sustained price increase and improved liquidity, may not be realized.
- The reduction in outstanding shares without a corresponding reduction in authorized shares increases the number of shares available for issuance, potentially leading to future dilution of existing stockholders.
- The current economic environment and company debt could limit the ability to raise new equity capital.
- Nasdaq may determine that it is not in the public interest to maintain the company's listing due to a series of reverse stock splits, even if bid price compliance is met.
- The company is currently non-compliant with Nasdaq's Market Value of Listed Securities (MVLS) rule and faces potential delisting, with no assurance that a hearing will grant continued listing.
Future Outlook
The Board of Directors will determine, at its sole discretion and within 12 months of stockholder approval, whether to effect the reverse stock split and the exact ratio (between 1-for-2 and 1-for-250), based on factors such as the prevailing stock price and Nasdaq listing requirements. If implemented, this will be the company's final reverse stock split for a period of 36 months. The company intends to timely request a hearing before the Nasdaq Listing Qualifications Panel regarding its non-compliance with the Market Value of Listed Securities rule.
Management Comments
- The Board of Directors has unanimously approved and declared advisable the Reverse Stock Split and recommends that stockholders approve the amendment to the certificate of incorporation.
- The Board believes that it is prudent to seek stockholder approval for the Reverse Stock Split for the purpose of remaining in compliance with the Bid Price Rule, which the Company may or may not implement depending on the closing bid price for its common stock.
- The Board believes the increase in authorized but unissued shares resulting from the reverse stock split is appropriate for use to fund future operations and potential acquisitions.
Industry Context
Companies often resort to reverse stock splits to meet minimum bid price requirements for continued listing on major exchanges like Nasdaq. While a necessary step to avoid delisting, a history of multiple reverse splits in a short period, as seen with Bollinger Innovations, can signal underlying financial or operational challenges and often leads to a negative perception among investors, as it rarely results in a sustained increase in market capitalization or long-term stock price stability. Institutional investors and brokers frequently have policies that discourage or prohibit investment in low-priced or highly volatile stocks, making compliance crucial for broader market access.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Proposal to amend the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-250. | To be determined by the Board within 12 months of stockholder approval | Aims to increase per-share price to meet Nasdaq listing requirements, but also increases authorized unissued shares and could lead to dilution. |
Stakeholder Impact
- Shareholders face potential dilution from an increased pool of authorized but unissued shares.
- Shareholders may incur higher transaction costs if they own 'odd lots' (less than 100 shares) after the reverse stock split.
- The company's Nasdaq listing status remains uncertain, which could impact the liquidity and marketability of shares for all stockholders.
- The repeated need for reverse stock splits may erode investor confidence and negatively impact the company's reputation in the market.
Next Steps
- Stockholders will vote on the reverse stock split and adjournment proposals at the Special Meeting on September 11, 2025.
- If approved, the Board of Directors will determine, at its discretion, the exact reverse stock split ratio and the timing of its implementation within 12 months.
- The company intends to timely request a hearing before the Nasdaq Listing Qualifications Panel regarding its non-compliance with the MVLS Listing Rule to appeal delisting.
Key Dates
| Date | Description |
|---|---|
| 2012-10-02 | Original Certificate of Incorporation filed. |
| 2021-11-05 | Second Amended and Restated Certificate of Incorporation filed. |
| 2022-03-08 | Amendment to Certificate of Incorporation. |
| 2022-07-26 | Amendment to Certificate of Incorporation. |
| 2022-09-07 | Received Nasdaq deficiency notice for Bid Price Rule non-compliance. |
| 2023-01-30 | Amendment to Certificate of Incorporation. |
| 2023-05-03 | Amendment to Certificate of Incorporation. |
| 2023-05-04 | Effected a 1-for-25 reverse stock split. |
| 2023-08-10 | Amendment to Certificate of Incorporation. |
| 2023-08-11 | Effected an additional 1-for-9 reverse stock split. |
| 2023-09-05 | Nasdaq extended deadline for Bid Price Rule compliance. |
| 2023-09-06 | Received Nasdaq letter for not meeting Bid Price Rule deadline; requested a hearing. |
| 2023-10-25 | Nasdaq Panel granted continued listing until January 22, 2024. |
| 2023-12-20 | Amendment to Certificate of Incorporation. |
| 2023-12-21 | Effected a 1-for-100 reverse stock split. |
| 2024-01-22 | Deadline to demonstrate Bid Price Rule compliance. |
| 2024-01-24 | Announced regaining compliance with Bid Price Rule. |
| 2024-09-16 | Received Nasdaq notice of non-compliance with Bid Price Rule (cumulative ratio issue). |
| 2024-09-16 | Amendment to Certificate of Incorporation. |
| 2024-09-17 | Implemented a 1-for-100 reverse stock split. |
| 2024-10-16 | Announced regaining compliance with Bid Price Rule. |
| 2025-01-12 | Deadline for universal proxy rules notice for 2026 annual meeting. |
| 2025-02-14 | Amendment to Certificate of Incorporation. |
| 2025-02-18 | Effected a 1-for-60 reverse stock split. |
| 2025-02-25 | Received Nasdaq notice of non-compliance with MVLS Listing Rule. |
| 2025-04-10 | Amendment to Certificate of Incorporation. |
| 2025-04-11 | Effected an additional 1-for-100 reverse stock split. |
| 2025-05-30 | Amendment to Certificate of Incorporation. |
| 2025-06-02 | Effected an additional 1-for-100 reverse stock split. |
| 2025-07-25 | Amendment to Certificate of Incorporation. |
| 2025-08-04 | Effected a 1-for-250 reverse stock split. |
| 2025-08-14 | Common stock began closing below $1.00. |
| 2025-08-22 | Record date for the Special Meeting of Stockholders. |
| 2025-08-25 | Deadline to regain compliance with MVLS Listing Rule. |
| 2025-08-26 | Received Nasdaq notice of non-compliance with MVLS Listing Rule (failed to regain compliance). |
| 2025-08-29 | Proxy Statement mailed to stockholders. |
| 2025-09-10 | Deadline for voting by Internet or telephone (11:59 P.M. ET). |
| 2025-09-11 | Special Meeting of Stockholders at 9:30 A.M. ET. |
| 2025-10-21 | Deadline for Rule 14a-8 stockholder proposals for the 2026 annual meeting. |
| 2025-11-13 | Earliest deadline for non-Rule 14a-8 stockholder proposals for the 2026 annual meeting. |
| 2025-12-13 | Latest deadline for non-Rule 14a-8 stockholder proposals for the 2026 annual meeting. |
Recommendation
sellThe company's history of repeated non-compliance with Nasdaq listing rules, necessitating numerous reverse stock splits in a short period, indicates severe and persistent underlying challenges. The current proposal is a reactive measure to avoid delisting, not a proactive growth strategy. This pattern suggests a highly speculative investment with significant downside risk and a lack of sustained positive momentum, making it unsuitable for most investors.
Keywords
Reverse Stock Split, Nasdaq Listing, Delisting Risk, Stockholder Meeting, Corporate Governance, Shareholder Vote, BINI, Capital Market Compliance, Proxy Solicitation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.